Please login to the form below

Not currently logged in
Email:
Password:

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

Boehringer facebook syrum 

German drug maker Boehringer Ingelheim has launched its highly anticipated 'social game' Syrum across Europe.

Developed as an application for Facebook, Syrum is the first of its kind for the pharma industry and aims to educate players through a combination of gaming and social interactivity.

Unveiled at a consumer-style launch at the London Science Museum, the game spent more than two years in development and has been designed to help explain some of the processes of medicine research.

"The use of gaming in education has been put to effective use all over the world as more organisations appreciate that humans are better motivated and stimulated by interaction, fun and engagement", said Dr Jez Rose, behavioural psychologist from Buckinghamshire.

"Syrum is a fantastic example of how fun gaming can be used to provide educational delivery, whilst maintaining interest and engagement through a logical platform-learning style."

Based around a virtual laboratory, Syrum players can develop their own imaginary medicines based around molecular compounds that can also be traded with other players.

"The research driven pharmaceutical industry is immersed in education – whether aimed at medical or pharmaceutical professionals or providing information directly to the public," said John Pugh, director of digital, Boehringer.

"Gaming is an experimental way for Boehringer Ingelheim to do this. The challenge is to do this in a truly engaging, educational and entertaining way that immerses the player."

Built into Facebook, Syrum has initially been launched in a beta format outside the US and Canada, but the company is planning a full global launch next year.

14th September 2012

From: Marketing, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics